Table 2.
Cox proportional hazards models for 5 year overall mortality in the Kaiser Permanente validation cohort
| Univariate analysis |
Multivariate analysis |
|||
|---|---|---|---|---|
| Hazard ratio (95% CI) |
Wald test p value |
Hazard ratio (95% CI) |
Likelihood ratio test p value |
|
| Risk category* | ||||
| High risk | 2·16 (1·39–3·36) | 0·0007 | 2·04 (1·28–3·26) | 0·0016 |
| Intermediate risk | 1·60 (0·98–2·60) | 0·0610 | 1·66 (1·00–2·74) | 0·0436 |
| Age >65 years | 1·55 (1·14–2·10) | 0·0054 | 1·66 (1·21–2·29) | 0·0016 |
| Sex (female) | 0·55 (0·41–0·74) | 0·0001 | 0·67 (0·49–0·92) | 0·0123 |
| Never smoker | 0·59 (0·32–1·09) | 0·0917 | 0·83 (0·44–1·55) | 0·5438 |
| Histology† | ||||
| Large-cell carcinoma | 0·96 (0·42–2·17) | 0·9139 | 0·64 (0·26–1·59) | 0·3038 |
| Mixed | 0·98 (0·43–2·22) | 0·9615 | 0·85 (0·37–1·95) | 0·6932 |
| NSCLC (not otherwise specified) | 1·13 (0·89–1·93) | 0·1659 | 1·18 (0·79–1·75) | 0·4320 |
| Tumour size >4 cm | 1·42 (0·97–2·07) | 0·0697 | 1·10 (0·73–1·66) | 0·6435 |
NSCLC=non-small-cell lung cancer.
Compared with low-risk group.
Compared with adenocarcinoma.